Inventor
FRETZ HEINZ
CH19 patents
⚠️ This page may combine multiple inventors who share the name “FRETZ HEINZ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IDORSIA PHARMACEUTICALS LTD
7 patentsUS11241431B2Feb 8, 2022
N-substituted indole derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD6 citations83
US11325899B2May 10, 2022
Benzofurane and benzothiophene derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD6 citations73
US11712438B2Aug 1, 2023
Phenyl derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD2 citations71
US11446298B2Sep 20, 2022
Pyrimidine derivatives
IDORSIA PHARMACEUTICALS LTD5 citations71
US12011444B2Jun 18, 2024
N-substituted indole derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD2 citations70
US11839613B2Dec 12, 2023
Pyrimidine derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD1 citations61
US9920010B2Mar 20, 2018
CXCR7 receptor modulators
IDORSIA PHARMACEUTICALS LTD2 citations58
ACTELION PHARMACEUTICALS LTD
5 patentsUS8048881B2Nov 1, 2011
Pyrimidine derivatives and their use as P2Y12 receptor antagonists
ACTELION PHARMACEUTICALS LTD9 citations82
US7714132B2May 11, 2010
Tetrahydropyridoindole derivatives
ACTELION PHARMACEUTICALS LTD7 citations71
US9428456B2Aug 30, 2016
1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives
ACTELION PHARMACEUTICALS LTD3 citations70
US7544691B2Jun 9, 2009
Guanidine derivatives
ACTELION PHARMACEUTICALS LTD7 citations69
US7727979B2Jun 1, 2010
Guanidine derivatives and their use as neuropeptide FF receptor antagonists
ACTELION PHARMACEUTICALS LTD0 citations48
AISSAOUI HAMED
2 patentsUS8697869B2Apr 15, 2014
3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators
AISSAOUI HAMED6 citations71
US8575158B2Nov 5, 2013
1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators
AISSAOUI HAMED2 citations60